4Eger E Ⅱ. New inhaled anesthetics. Anesthesiology,1994,80:906-922.
5Stein J H, DeMeester TR, Naspetti R, et al. Three-dimensional imaging of the lower esophageal sphincter in gastresophageal reflux disease. Ann Surg, 1991,214: 374-384.
6Bombeek CT, Vaz O, DeSalvo J, et al. Computerized axial manometry of the esophagus. Ann Surg, 1987,206 : 465-472.
7Hashim MA,Waterman AE, Pearson H. Comparison of the effects of halothane and isoflurane in combination with nitrous oxide on lower esophageal sphincter pressure and barrier pressure in anaesthetized dogs. Vet Rec, 1995,137:658-661.
8BAUM V C, YEMEN T A, BAUM L D.Immediate 8% sevoflume iuduetion in children; a comparison with in-cremental sevofluraue and incremental halothane [J].Anesth Analg, 1997, 85(2) :313.
9刘明政，中华麻醉学杂志，1996年，16卷，604页
10Katoh T,Ikeda k.The minimum alveolar concentration (MAC)of sevoflurane in humans.Anesthesiology,1987,66:301-303.
8Fanelli G, Berti M, Casati A, et al. Fast-track anaesthesia for laparoscoptic cholecystectomy : a prospective, randomized, multicentre, blind comparison of desflurane-remifentanil or seveflurane-remifentanil[ J]. Eur J Anesthesial,2006,23(10) :861-868.
9Bordes M, Cros AM. Inhalation induction with sevoflurane in paediatrics :what is new? [ J]. Ann Fr Anesth Reanim ,2006 ,25 :413-416.
10Evans NR, Gardner SV, James MF, et al. The Proseal laryrgeal mask : results of a descriptive trail with experience of 300 cases[ J ]. Br J An-aesth,2002,88 (4) :534-539.
